Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Harrington

Showing results (361-370 of 368) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 368 results.
Cell Reports|January 4, 2026
Single-cell resolution of an open chromatin signature in persister tumor cellsMihai Gabriel Dumbrava, Wazim Mohammed Ismail, Leticia Sandoval, et al.
Journal of Applied Clinical Medical Physics|July 20, 2024
Evaluation of knowledge-based planning models for male pelvic CBCT-based online adaptive radiotherapy on conventional linear acceleratorsRiley C Tegtmeier, Edward L Clouser, Brady S Laughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance ConsortiumJohn Z Ayanian, Elizabeth A Chrischilles, Robert H Fletcher, et al.
Epidemiology and Infection|October 14, 2014
Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapinsE B Shelley, D O'Rourke, K Grant, et al.
Cancer Research|September 2, 2000
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study CollaboratorsS A Gayther, K A de Foy, P Harrington, et al.
Scientific Reports|February 8, 2014
Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C statusJ M Cunningham, M S Cicek, N B Larson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian CancerAmanda J Compadre, Lillian N van Biljon, Mark C Valentine, et al.
Gynecologic Oncology|April 11, 2026
Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleedingJamie N Bakkum-Gamez, Shariska P Harrington, Seth W Slettedahl, et al.
Pageof 37

Showing results (361-370 of 368) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 368 results.
Cell Reports|January 4, 2026
Single-cell resolution of an open chromatin signature in persister tumor cellsMihai Gabriel Dumbrava, Wazim Mohammed Ismail, Leticia Sandoval, et al.
Journal of Applied Clinical Medical Physics|July 20, 2024
Evaluation of knowledge-based planning models for male pelvic CBCT-based online adaptive radiotherapy on conventional linear acceleratorsRiley C Tegtmeier, Edward L Clouser, Brady S Laughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance ConsortiumJohn Z Ayanian, Elizabeth A Chrischilles, Robert H Fletcher, et al.
Epidemiology and Infection|October 14, 2014
Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapinsE B Shelley, D O'Rourke, K Grant, et al.
Cancer Research|September 2, 2000
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study CollaboratorsS A Gayther, K A de Foy, P Harrington, et al.
Scientific Reports|February 8, 2014
Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C statusJ M Cunningham, M S Cicek, N B Larson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian CancerAmanda J Compadre, Lillian N van Biljon, Mark C Valentine, et al.
Gynecologic Oncology|April 11, 2026
Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleedingJamie N Bakkum-Gamez, Shariska P Harrington, Seth W Slettedahl, et al.
Pageof 37